1. Home
  2. CTRE vs RGEN Comparison

CTRE vs RGEN Comparison

Compare CTRE & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareTrust REIT Inc.

CTRE

CareTrust REIT Inc.

HOLD

Current Price

$37.21

Market Cap

9.9B

Sector

Real Estate

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$194.54

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRE
RGEN
Founded
2013
1981
Country
United States
United States
Employees
N/A
2000
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
10.0B
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
CTRE
RGEN
Price
$37.21
$194.54
Analyst Decision
Buy
Buy
Analyst Count
10
12
Target Price
$42.40
★ $167.67
AVG Volume (30 Days)
★ 1.6M
910.6K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
★ 3.44%
N/A
EPS Growth
96.25
★ 286.96
EPS
★ 0.74
0.24
Revenue
★ $476,393,000.00
$141,236,000.00
Revenue This Year
$5.97
$14.30
Revenue Next Year
$13.39
$14.52
P/E Ratio
★ $50.18
$807.88
Revenue Growth
★ 60.79
35.10
52 Week Low
$32.79
$100.99
52 Week High
$43.62
$198.87

Technical Indicators

Market Signals
Indicator
CTRE
RGEN
Relative Strength Index (RSI) 33.44 70.11
Support Level $36.91 $159.22
Resistance Level $41.66 N/A
Average True Range (ATR) 0.76 6.37
MACD -0.04 1.63
Stochastic Oscillator 10.16 86.80

Price Performance

Historical Comparison
CTRE
RGEN

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: